Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Docosa-Hexanoic Acid (DHA) Supplements During Pregnancy on Newborn Outcomes in India (DHANI)

NCT01580345 is registered in ClinicalTrials.gov with Centre for Chronic Disease Control, India as lead sponsor.

NCT NCT01580345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01580345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Docosa-Hexanoic Acid (DHA) Supplements During Pregnancy on Newborn Outcomes in India (DHANI)
Lead sponsor
Centre for Chronic Disease Control, India
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2015
Completion date
December 9, 2016
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy